MT 1005k
Alternative Names: MT-1005κLatest Information Update: 28 Oct 2024
Price :
$50 *
At a glance
- Originator Shaanxi Micot Technology Co
- Class Analgesics; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Oct 2024 No recent reports of development identified for research development in Pain in China (Parenteral)
- 04 Sep 2020 Early research in Pain in China (Parenteral) Before September 2020 (Shaanxi Micot Technology September 2020)